157 related articles for article (PubMed ID: 32266453)
21. Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer.
Kim C; Chon H; Kang B; Kim K; Jeung HC; Chung H; Noh S; Rha S
BMC Cancer; 2013 Aug; 13():394. PubMed ID: 23967865
[TBL] [Abstract][Full Text] [Related]
22. Gastric epithelial dysplasia: characteristics and long-term follow-up results after endoscopic resection according to morphological categorization.
Baek DH; Kim GH; Park DY; Lee BE; Jeon HK; Lim W; Song GA
BMC Gastroenterol; 2015 Feb; 15():17. PubMed ID: 25886985
[TBL] [Abstract][Full Text] [Related]
23. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.
Maehata Y; Nakamura S; Fujisawa K; Esaki M; Moriyama T; Asano K; Fuyuno Y; Yamaguchi K; Egashira I; Kim H; Kanda M; Hirahashi M; Matsumoto T
Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of metachronous multiple early gastric cancers after endoscopic mucosal resection.
Nasu J; Doi T; Endo H; Nishina T; Hirasaki S; Hyodo I
Endoscopy; 2005 Oct; 37(10):990-3. PubMed ID: 16189772
[TBL] [Abstract][Full Text] [Related]
25. Incidence of metachronous gastric cancer in the remnant stomach after synchronous multiple cancer surgery.
Nozaki I; Hato S; Kobatake T; Ohta K; Kubo Y; Nishimura R; Kurita A
Gastric Cancer; 2014 Jan; 17(1):61-6. PubMed ID: 23624766
[TBL] [Abstract][Full Text] [Related]
26. The Incidence and Risk Factors for Metachronous Gastric Cancer in the Remnant Stomach after Gastric Cancer Surgery.
Choi Y; Kim N; Yoon H; Shin CM; Park YS; Lee DH; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH
Gut Liver; 2022 May; 16(3):366-374. PubMed ID: 34462394
[TBL] [Abstract][Full Text] [Related]
27. Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.
Iguchi M; Kato J; Yoshida T; Yamamoto Y; Nakachi K; Fukatsu K; Mori Y; Maeda Y; Moribata K; Shingaki N; Niwa T; Deguchi H; Inoue I; Maekita T; Tamai H; Ichinose M
Int J Cancer; 2016 Sep; 139(5):1150-6. PubMed ID: 27083518
[TBL] [Abstract][Full Text] [Related]
28. Function-preserving gastrectomy for gastric cancer in Japan.
Nomura E; Okajima K
World J Gastroenterol; 2016 Jul; 22(26):5888-95. PubMed ID: 27468183
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for metachronous gastric carcinoma development after endoscopic resection of gastric dysplasia: Retrospective, single-center study.
Moon HS; Yun GY; Kim JS; Eun HS; Kang SH; Sung JK; Jeong HY; Song KS
World J Gastroenterol; 2017 Jun; 23(24):4407-4415. PubMed ID: 28706423
[TBL] [Abstract][Full Text] [Related]
30. The incidences of metachronous multiple gastric cancer after various types of gastrectomy: analysis of data from a nationwide Japanese survey.
Kinami S; Aizawa M; Yamashita H; Kumagai K; Kamiya S; Toda M; Takahata T; Fujisaki M; Miyamoto H; Kusanagi H; Kobayashi K; Washio M; Hosoda K; Kosaka T
Gastric Cancer; 2021 Jan; 24(1):22-30. PubMed ID: 32780194
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a pylorus-preserving gastrectomy for patients preoperatively diagnosed with early gastric cancer located in the middle third of the stomach.
Ikeguchi M; Hatada T; Yamamoto M; Miyake T; Matsunaga T; Fukuda K; Saito H; Tatebe S
Surg Today; 2010 Mar; 40(3):228-33. PubMed ID: 20180075
[TBL] [Abstract][Full Text] [Related]
32. Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance?
Nakajima T; Oda I; Gotoda T; Hamanaka H; Eguchi T; Yokoi C; Saito D
Gastric Cancer; 2006; 9(2):93-8. PubMed ID: 16767364
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of intraoperative manual dilatation of pylorus in pylorus-preserving gastrectomy: a retrospective analysis.
Zhu CC; Kim TH; Berlth F; Park SH; Suh YS; Kong SH; Lee HJ; Cao H; Yang HK
Gastric Cancer; 2018 Sep; 21(5):864-870. PubMed ID: 29536295
[TBL] [Abstract][Full Text] [Related]
34. Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication.
Okada K; Suzuki S; Naito S; Yamada Y; Haruki S; Kubota M; Nakajima Y; Shimizu T; Ando K; Uchida Y; Hirasawa T; Fujisaki J; Tsuchida T
Gastrointest Endosc; 2019 Jun; 89(6):1152-1159.e1. PubMed ID: 30825537
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis.
Lin JX; Wang ZK; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
Cancer Commun (Lond); 2019 Feb; 39(1):4. PubMed ID: 30744696
[TBL] [Abstract][Full Text] [Related]
36. Oncologic safety of pylorus-preserving gastrectomy in the aspect of micrometastasis in lymph nodes at stations 5 and 6.
Kim BH; Hong SW; Kim JW; Choi SH; Yoon SO
Ann Surg Oncol; 2014 Feb; 21(2):533-8. PubMed ID: 24008556
[TBL] [Abstract][Full Text] [Related]
37. [Application of pylorus-vagus-preserving gastrectomy in early gastric cancer in middle third of stomach].
Hu J; Shao Q; Sun Y; Xu X; Xu J
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(14):1096-9. PubMed ID: 26081212
[TBL] [Abstract][Full Text] [Related]
38. Function-preserving gastrectomy for early gastric cancer.
Hiki N; Nunobe S; Kubota T; Jiang X
Ann Surg Oncol; 2013 Aug; 20(8):2683-92. PubMed ID: 23504120
[TBL] [Abstract][Full Text] [Related]
39. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer.
Ikeguchi M; Ohfuji S; Oka A; Tsujitani S; Maeda M; Kaibara N
Hepatogastroenterology; 1995; 42(5):672-6. PubMed ID: 8751233
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency ablation for metachronous hepatic metastases from gastric cancer.
Kim HO; Hwang SI; Hong HP; Yoo CH
Surg Laparosc Endosc Percutan Tech; 2009 Jun; 19(3):208-12. PubMed ID: 19542847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
